Skip to main content
ArcticZymes Technologies logo

ArcticZymes Technologies — Investor Relations & Filings

Ticker · AZT ISIN · NO0010014632 LEI · 5967007LIEEXZXGR7K47 BR Manufacturing
Filings indexed 968 across all filing types
Latest filing 2022-04-28 Earnings Release
Country NO Norway
Listing BR AZT

About ArcticZymes Technologies

https://arcticzymes.com/

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and commercialization of novel recombinant enzymes. Leveraging over 30 years of expertise, the company discovers and engineers enzymes from cold-adapted Arctic marine organisms. These enzymes are designed to solve specific challenges in molecular applications, demonstrating high efficiency in demanding conditions such as low temperatures and high salinity. The product portfolio, including Salt Active Nucleases (SAN) and Cod Uracil-DNA Glycosylase, serves global partners in molecular diagnostics, gene therapy, vaccine production, and biomanufacturing. All products are manufactured at its ISO 13485 certified facility, ensuring high quality and performance for research and commercial use.

Recent filings

Filing Released Lang Actions
ArcticZymes Technologies Q1 2022 Results
Earnings Release Classification · 98% confidence The document is titled "ArcticZymes Technologies Q1 2022 Results" and immediately presents key financial figures (sales, EBITDA) for the first quarter. It includes CEO commentary and highlights specific operational achievements for the period. This structure is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results, focusing on key highlights. It is too brief and focused on highlights to be a full Interim Report (IR). The document also mentions a presentation and webcast, but the primary content is the results announcement itself, making ER the most appropriate classification over RPA. Q1 2022
2022-04-28 English
ArcticZymes Technologies Q1 2022 Results
Earnings Release Classification · 100% confidence The document is titled 'ArcticZymes Technologies Q1 2022 Results' and provides key financial highlights (sales, EBITDA, cash flow) for the first quarter of 2022. This content structure—a brief summary of period results with commentary—is characteristic of an Earnings Release (ER). Although it mentions that the full 'results, report and presentation' will be available elsewhere, the text provided is the initial announcement of the results themselves, not just an announcement of the report's availability. Therefore, it fits the definition of an Earnings Release (ER). The document length (3183 chars) is consistent with a brief release rather than a comprehensive Interim Report (IR). Q1 2022
2022-04-28 English
ArcticZymes Technologies Q1 2022 Presentation
Report Publication Announcement Classification · 98% confidence The document is titled 'ArcticZymes Technologies Q1 2022 Presentation' and explicitly states that the company 'presents on April 28, 2022 at 08:30 its interim report for the first quarter 2022.' Crucially, the last line states, 'Please find the presentation attached.' This indicates the document itself is an announcement about the presentation/report release, not the full report or the presentation slides themselves. Since it is announcing the release of an interim report presentation, the most fitting category is Investor Presentation (IP) if it were the slides, or Report Publication Announcement (RPA) because it is announcing the publication/presentation. Given the short length (339 chars) and the instruction to use RPA when a document announces a report is attached/published, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule.
2022-04-28 English
ArcticZymes Technologies ASA - Annual Report 2021
Annual Report Classification · 100% confidence The document is titled 'ArcticZymes Technologies ASA 2021 Annual Report' and contains detailed sections typical of an annual report, including a CEO letter, Board of Directors' report, corporate social responsibility, principles of corporate governance, remuneration report, financial statements for the group and parent company, notes to the financial statements, statement by the Board and CEO, and an independent auditor's report. The content includes comprehensive financial performance data, business overview, product offerings, market analysis, and strategic initiatives for the full fiscal year 2021. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. These characteristics align with the definition of an Annual Report (10-K). FY 2021
2022-04-26 English
ArcticZymes Technologies ASA - Annual Report 2021
Annual Report Classification · 100% confidence The document is titled 'Annual Report' and contains comprehensive sections including the Board of Directors' report, financial statements, notes to the financial statements, and an independent auditor's report for the fiscal year 2021. It provides detailed business performance, operational highlights, and financial data, fitting the definition of an Annual Report (10-K). FY 2021
2022-04-26 English
ArcticZymes Technologies ASA - Annual Report 2021
Report Publication Announcement Classification · 100% confidence The document explicitly states it is the 'ArcticZymes Technologies ASA - Annual Report 2021' and mentions that the report is 'attached to this stock exchange notice' and 'published'. Given the very short length (794 chars) and the nature of the text announcing the availability of the full report rather than containing the full report content itself, this fits the definition of a Report Publication Announcement (RPA) according to Rule #2 (The 'MENU VS MEAL' Rule). Although the content is about the Annual Report (10-K), the document *type* is the announcement of its publication.
2022-04-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.